Key result
Longer RSV P peptides achieve sub-micromolar affinity to enable a robust M76-validated inhibition assay.
Why the study?
In vitro screening of antivirals targeting the RSV N-P interaction requires a molecular model, but the flexibility and phosphorylation status of C-terminal P peptides may bias inhibition assays.
The study establishes optimized parameters for a robust RSV N-P inhibition assay using fluorescence polarization, validated with the antiviral molecule M76.
May aid RSV antiviral screening in vitro; leaves open translation to clinical therapies.
The interaction between Respiratory Syncytial Virus phosphoprotein P and nucleoprotein N is essential for the formation of the holo RSV polymerase that carries out replication. In vitro screening of antivirals targeting the N-P protein interaction requires a molecular interaction model, ideally consisting of a complex between N protein and a short peptide corresponding to the C-terminal tail of the P protein. However, the flexibility of C-terminal P peptides as well as their phosphorylation status play a role in binding and may bias the outcome of an inhibition assay. We therefore investigated binding affinities and dynamics of this interaction by testing two N protein constructs and P peptides of different lengths and composition, using nuclear magnetic resonance and fluorescence polarization (FP). We show that, although the last C-terminal Phe241 residue is the main determinant for anchoring P to N, only longer peptides afford sub-micromolar affinity, despite increasing mobility towards the N-terminus. We investigated competitive binding by peptides and small compounds, including molecules used as fluorescent labels in FP. Based on these results, we draw optimized parameters for a robust RSV N-P inhibition assay and validated this assay with the M76 molecule, which displays antiviral properties, for further screening of chemical libraries.
No takes yet. Share an insight, caveat, or question.
Khodjoyan et al. (2022) studied Respiratory Syncytial Virus. N protein constructs and P peptides was evaluated on Binding affinities and dynamics of N-P interaction. Investigation of RSV N and P protein interactions revealed that longer P peptides afford sub-micromolar affinity, allowing optimization of a robust inhibition assay validated with the M76 molecule.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: